Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.
Yamamoto C, Minakata D, Koyama S, Sekiguchi K, Fukui Y, Murahashi R, Nakashima H, Matsuoka S, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Nagayama T, Umino K, Nakano H, Morita K, Yamasaki R, Ashizawa M, Ueda M, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Yamamoto C, et al. Among authors: ueda m. Blood. 2022 Aug 11;140(6):594-607. doi: 10.1182/blood.2021015220. Blood. 2022. PMID: 35580269 Free PMC article.
[Benefits of mycophenolate mofetil for refractory graft-versus-host disease].
Mori M, Muroi K, Matsuyama T, Oka S, Ono Y, Yamamoto C, Uesawa M, Okabe H, Matsu H, Tatara R, Kikuchi Y, Fujiwara S, Kikuchi S, Sato K, Ueda M, Toshima M, Ozaki K, Takatoku M, Nagai T, Ozawa K. Mori M, et al. Among authors: ueda m. Rinsho Ketsueki. 2007 Aug;48(8):624-31. Rinsho Ketsueki. 2007. PMID: 17867298 Japanese.
Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
Oka S, Muroi K, Mori M, Matsuyama T, Fujiwara S, Oh I, Ono Y, Kikuchi S, Sato K, Ueda M, Toshima M, Ozaki K, Takatoku M, Nagai T, Ozawa K. Oka S, et al. Among authors: ueda m. Intern Med. 2007;46(19):1669-70. doi: 10.2169/internalmedicine.46.0345. Epub 2007 Oct 1. Intern Med. 2007. PMID: 17917331 Free article. No abstract available.
Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
Meguro A, Ozaki K, Sato K, Oh I, Fujiwara S, Hosonuma R, Sasazaki M, Kikuchi Y, Hirata Y, Yamamoto C, Uesawa M, Kobayashi H, Matsu H, Okabe H, Uehara E, Nishikawa A, Tatara R, Hatano K, Yamamoto C, Matsuyama T, Toshima M, Ueda M, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K. Meguro A, et al. Among authors: ueda m. Leuk Lymphoma. 2012 Jan;53(1):43-9. doi: 10.3109/10428194.2011.600486. Epub 2011 Aug 24. Leuk Lymphoma. 2012. PMID: 21864040
Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation.
Yamamoto C, Nakashima H, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Mashima K, Nagayama T, Umino K, Minakata D, Nakano H, Morita K, Yamasaki R, Sugimoto M, Ishihara Y, Ashizawa M, Hatano K, Sato K, Oh I, Fujiwara SI, Ueda M, Ohmine K, Muroi K, Kanda Y. Yamamoto C, et al. Among authors: ueda m. Blood Adv. 2019 Nov 12;3(21):3266-3277. doi: 10.1182/bloodadvances.2019000745. Blood Adv. 2019. PMID: 31698458 Free PMC article.
Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma.
Hatano K, Fujiwara SI, Umino K, Ikeda T, Nakano H, Mashima K, Kawaguchi SI, Ito S, Toda Y, Nagayama T, Minakata D, Yamasaki R, Morita K, Yamamoto C, Ashizawa M, Sato K, Ueda M, Ohmine K, Kanda Y. Hatano K, et al. Among authors: ueda m. Ann Hematol. 2022 Jun;101(6):1211-1216. doi: 10.1007/s00277-022-04832-9. Epub 2022 Apr 11. Ann Hematol. 2022. PMID: 35403851
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Yamamoto C, Minakata D, Yokoyama D, Furuki S, Noguchi A, Koyama S, Oyama T, Murahashi R, Nakashima H, Ikeda T, Kawaguchi SI, Hyodo K, Toda Y, Ito S, Nagayama T, Umino K, Morita K, Ashizawa M, Ueda M, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Yamamoto C, et al. Among authors: ueda m. Transplant Cell Ther. 2024 Jan;30(1):118.e1-118.e15. doi: 10.1016/j.jtct.2023.10.001. Epub 2023 Oct 5. Transplant Cell Ther. 2024. PMID: 37802181
4,684 results